. 1986 Sep;45(10):2447-2450.

Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents

D T Vistica et al. Fed Proc. 1986 Sep.

. 1986 Sep;45(10):2447-2450.

No abstract available

Similar articles

Cellular pharmacokinetics of the phenylalanine mustards.
Vistica DT. Vistica DT. Pharmacol Ther. 1983;22(3):379-406. doi: 10.1016/0163-7258(83)90009-8. Pharmacol Ther. 1983. PMID: 6361804 Review. No abstract available.
Ethanol mustard cytotoxicity in vitro toward murine leukemia and bone marrow progenitor cells.
Naujokaitis SA, Fisher JM, Rabinovitz M. Naujokaitis SA, et al. Res Commun Chem Pathol Pharmacol. 1981 Aug;33(2):305-18. Res Commun Chem Pathol Pharmacol. 1981. PMID: 7302378
Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
Vistica DT, Toal JN, Rabinovitz M. Vistica DT, et al. Mol Pharmacol. 1978 Nov;14(6):1136-42. Mol Pharmacol. 1978. PMID: 732811 No abstract available.
Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
Vistica DT, Toal JN, Rabinovitz M. Vistica DT, et al. Biochem Pharmacol. 1978;27(24):2865-70. doi: 10.1016/0006-2952(78)90202-2. Biochem Pharmacol. 1978. PMID: 736979 No abstract available.
Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P, Catsoulacos D. Catsoulacos P, et al. Anticancer Res. 1994 Nov-Dec;14(6B):2525-8. Anticancer Res. 1994. PMID: 7872677 Review.

Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
Takada Y, Greig NH, Vistica DT, Rapoport SI, Smith QR. Takada Y, et al. Cancer Chemother Pharmacol. 1991;29(2):89-94. doi: 10.1007/BF00687316. Cancer Chemother Pharmacol. 1991. PMID: 1760863